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RESEARCH ARTICLE

Open Access

A novel mechanism of cell growth regulation by
Cell Cycle and Apoptosis Regulatory Protein
(CARP)-1
Research article

Yan Jiang1,5,6, Vineshkumar T Puliyappadamba2, Liyue Zhang5,6, Wenjuan Wu2, Anil Wali2,3, Michael B Yaffe4,
Joseph A Fontana1 and Arun K Rishi*2

Abstract
Background: CARP-1/CCAR1, a perinuclear phospho-protein, regulates signaling by adriamycin, steroids, or growth
factors. However, intracellular events that regulate CARP-1-dependent cell growth are not fully understood.
Results: Here we investigated whether CARP-1 is involved in signaling induced by the protein kinase A inhibitor H89.
Treatments of human breast cancer cells with H89 resulted in apoptosis that involved enhanced CARP-1 threonine
phosphorylation and expression. Depletion of CARP-1, on the other hand, abrogates apoptosis induced by H89. CARP1 binds with signal transducer TAZ and over-expression of TAZ inhibits apoptosis by CARP-1. CARP-1 (651-759) interacts
with a novel, N-terminal epitope of TAZ. H89 treatment stimulates threonine phosphorylation of CARP-1 (651-759),
while substitution of threonine667 to alanine interferes with its binding with TAZ and apoptosis by H89. In addition,
expression of wild type or CARP-1 (651-759) causes loss of c-myc expression due, in part, to suppression of c-myc
transcription.
Conclusions: CARP-1 threonine667 regulates H89-dependent signaling by a novel pathway that involves modulation of
CARP-1 interaction with TAZ and transcriptional down-regulation of c-myc.
Background
Apoptosis is essential in maintaining tissue homeostasis
in a host of conditions including development, wound
healing, and elimination of infectious pathogens. Defective apoptosis is often encountered in many diseases
including cancer [1,2]. Although, anticancer therapeutics
function in part by targeting apoptosis pathways, development of drug resistance remains a problem and therefore warrants identification and exploitation of additional
apoptosis transducers to effectively manage drug-resistant cancers. CARP-1/CCAR1 is a perinuclear protein
that functions in regulating signaling by growth factors as
well as chemotherapeutics such as adriamycin, etoposide,
and iressa [3,4]. CARP-1 is a phospho-protein that is a
target of phosphorylation by the DNA-damage induced
ATM kinase [5], and serves as a key co-activator of the
steroid/thyroid receptor family of transcription factors as
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well as tumor suppressor p53 [6]. Although ectopic
expression of CARP-1 diminishes levels of cell-cycle regulatory proteins such as c-myc, cyclin B, and topoisomerase IIα [3,4], the mechanisms by which CARP-1
regulates apoptosis and its role in various pathways that
regulate cell growth are yet to be fully elucidated.
We previously found that CARP-1 binds with 14-3-3/
stratifin [3]. 14-3-3 proteins belong to a family of highly
conserved and ubiquitously expressed proteins that regulate differentiation, cell cycle progression and apoptosis
signaling by binding with diverse intracellular proteins in
a manner dependent or independent of their phosphorylation [7]. TAZ, a transcriptional co-activator that has a
conserved WW, a coil-coil, a transactivation domains, as
well as has a C-terminal PDZ binding motif, is a ligand for
14-3-3 proteins [8]. TAZ is a negative regulator of peroxisome proliferator-activated receptor γ-dependent transcription, functions as a modulator of mesenchymal stem
cell differentiation by promoting Runx-2-dependent transcription, and is involved in development of multiple
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organs [9]. Lats kinase phosphorylates TAZ at serine 89
that in turn promotes its 14-3-3-mediated nuclear export
with consequent inhibition of its transcriptional co-activation function [8,10]. Since, CARP-1 is also a ligand of
14-3-3, the extent CARP-1 regulates signaling involving
TAZ is unclear.
Signaling by PKA has been implicated in numerous cellular processes that include modulation of other protein
kinases, regulation of intracellular calcium and transcription [11]. H89, a compound characterized in vitro as a
potent and selective inhibitor of PKA, is a competitive
antagonist of ATP at its binding site on the PKA catalytic
subunit and therefore has been extensively used to study
PKA functions [12,13]. A number of recent studies however have identified actions of H89 that are independent
of its effects on PKA [reviewed in [14]], suggesting likely
involvement of multiple pathways in transducing intracellular signaling by this compound. In this context, a
recent report revealed involvement of a nuclear hormone
receptor co-activator, NRIF3, in regulating H89-dependent apoptosis in breast cancer cells [15]. Since CARP-1
also associates with components of the mediator complex
to regulate expression of ER and GR target genes, as well
as functions as a p53 co-activator to transduce apoptosis
by chemotherapeutic adriamycin [6], we investigated
whether CARP-1 was also involved in regulating cell
growth inhibitory signaling by H89. Apoptosis signaling
induced by H89 caused elevated threonine phosphorylation as well as expression of CARP-1, while depletion of
CARP-1 interfered with H89 effects. H89 regulation of
CARP-1 interaction with TAZ and consequent repression
of c-myc elaborate a novel mechanism of cell growth
inhibition.

Results
H89 induces apoptosis, CARP-1 expression and threonine
phosphorylation, while loss of CARP-1 prevents apoptosis
by H89

To test whether H89 treatments induce apoptosis and the
extent CARP-1 is involved in growth inhibitory signaling
by H89, we first determined growth inhibition of HBC
and COS-7 cells by this agent. Exposure to H89 inhibited
cell growth (Figure 1A), in part, by enhancing apoptosis
(Figure 1B). Since H89 functions as an antagonist of the
PKA catalytic subunit (PKA-C), as well as inhibits MSK1
and ribosomal S6Kinase [14], we next determined
whether H89 signaling targeted these kinases to elicit cell
growth inhibition. For this purpose, we knocked-down
each of these kinases by utilizing on-target-plus Si-RNAs.
Western blot analyses of the HBC cells transfected separately with respective Si-RNAs revealed a greater than
70% to almost complete loss of PKA-Cα, S6K, or MSK1
expression when compared with corresponding scrambled Si-RNA-transfected controls, and the targeted
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depletion of either of these kinases failed to induce apoptosis (not shown). These preliminary findings raise the
possibility that different perhaps novel signaling pathway(s) are targeted by H89 to inhibit cell growth.
Whether apoptosis signaling by H89 involves CARP-1
was investigated next. CARP-1 levels were elevated in
cells that were treated with H89 or piceatannol (Figure
2A). Studies from our laboratory as well as by others have
revealed that CARP-1 is a phosphoprotein [4,16]. We further investigated whether H89 signaling targeted CARP-1
phosphorylation. HBC cells were either untreated or
treated with H89, and the CARP-1 protein was immunoprecipitated with anti-CARP-1 (α2) polyclonal antibodies
[3], followed by western blot analysis with anti-phosphotyrosine or anti-phospho-threonine antibodies. The data
revealed that while H89 did not cause elevated tyrosinephosphorylation of CARP-1, the level of threonine phosphorylated CARP-1 was elevated following exposure to
H89 (Figure 2B). Thus, H89 treatments cause increased
CARP-1 expression as well as its threonine phosphorylation.
The role of CARP-1 in regulating H89-dependent
apoptosis was further examined by utilizing multiple
MDA-MB-468 HBC sublines that stably express CARP-1
antisense as in methods. Wild-type HBC cells or CARP-1
antisense transfected sublines 1, 4, 9, and 10 were either
untreated or treated with H89, and cell lysates analyzed
for apoptosis as in methods. As shown in Figure 2C, H89dependent apoptosis was inhibited in cells that had
reduced levels of CARP-1 (sublines 9, 10) when compared to those with normal levels of CARP-1 (wild-type,
and sublines 1, 4). Taken together, these results demonstrate that H89-dependent inhibition of HBC cell growth
is likely independent of its targeting the PKA, S6K, or
MSK1 kinases, while involves elevated threonine phosphorylation and expression of CARP-1. Moreover, since
depletion of CARP-1 interferes with apoptosis by H89,
our data further underscore an important role for CARP1 in signaling by H89.
CARP-1 interacts with signal transducer TAZ, and
expression of TAZ inhibits CARP-1-dependent apoptosis

We have previously noted that expression of 14-3-3/stratifin interferes with apoptosis by CARP-1, and that CARP1 interacts with 14-3-3/stratifin [3]. Moreover, 14-3-3 was
also found to bind with TAZ protein in a manner dependent on TAZ serine phosphorylation [8]. Together with
the available GenBank database information indicating
CARP-1 as a TAZ-binding protein, we speculated that
CARP-1 may be part of a multi-protein cytoplasmic complex, and that CARP-1 interactions with 14-3-3 and/or
TAZ regulate signaling for cell growth. To test this possibility, we investigated whether CARP-1 interacts with
TAZ, the molecular basis of their interaction and the
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Figure 1 H89 attenuates cell proliferation (A) and enhances apoptosis (B). Cells growing in normal serum conditions were either untreated (noted as 0) or treated with noted doses of H89 for indicated time, followed by determination of cell proliferation by MTT assay (panel A) or apoptosis
(panel B) as in methods. Columns in histograms in panels A and B represent data from 3 independent experiments; bars, SE. Data in both panels were
analyzed using a two-tailed Student t test. For panel A, *P and **P < 0.0018 and 0.00002, respectively, and for panel B, *P and **P < 0.000026 and 0.0003,
respectively, compared to the corresponding untreated controls.

extent these interaction regulates apoptosis. In the first
instance, the cell lysates derived from MDA-MB-468 and
SKBR-3 breast cancer cells were subjected to immunoprecipitation with anti-CARP-1 (α2) polyclonal antibodies [3] followed by western immunoblotting with antiTAZ antibodies. As shown in figure 3A, TAZ protein was
detected in precipitates derived from anti-CARP-1 antibodies but not from anti-Gst-tag antibodies, suggesting
specific interaction between cellular CARP-1 and TAZ
proteins. We further ascertained CARP-1 interaction
with TAZ by utilizing HCT-116 colon cancer cells that
stably express myc-His-tagged wild-type CARP-1. These
cells were transfected with plasmids encoding flag-tagged
wild-type TAZ (pEF-TAZ-N-Flag) or mutant TAZ proteins (pEF-TAZ(-4)-N-Flag and pEF-TAZ(S89A)-N-Flag
that encode TAZ lacking PDZ binding and serine phosphorylation sites, respectively). The TAZ proteins from
respective cell lysates were immunoprecipitated with
anti-Flag-tag or anti-Gst-tag antibodies, and the immunoprecipitates subjected to western blot analysis with
anti-myc-tag antibody. The data revealed the presence of
CARP-1 in the immunoprecipitates derived from antiFlag-tag (lanes 2, 4, and 6) but not from anti-Gst-tag
(lanes 1, 3, and 5) antibodies (Figure 3B), suggesting that
CARP-1 binding with TAZ does not require the PDZ
motif or serine at position 89 of TAZ. Whether TAZ plays
a role in CARP-1-dependent apoptosis was investigated
next. HBC cells were transfected with vector plasmid
pEF1 or pEF1-TAZ-N-Flag followed by incubation of cells
with retroviruses encoding vector or myc-His-tagged
CARP-1 for a period of 48 h. CARP-1 transduction of
cells expressing vector plasmid resulted in ~3-fold
increase in apoptosis when compared with their vector

transduced counterparts, whereas expression of TAZ
inhibited apoptosis induced by CARP-1 (Figure 3C).
Since TAZ shuttles between cytoplasmic and nuclear
compartments [8] and CARP-1 is a perinuclear protein
[3], for their binding to occur, we ascertained the extent
the two proteins co-localize. To address this issue, the
COS-7 cells were transfected with a combination of plasmids encoding Flag-tagged wild-type TAZ and myc-Histagged wild-type CARP-1, followed by immunocytochemical detection of fluorescently-labelled respective
tagged proteins. As shown in Figure 3D, both the proteins
localized predominantly in the cytoplasmic compartment
with punctuate nuclear presence.
To map TAZ-interacting domain of CARP-1, cells were
transfected with plasmid encoding flag tagged TAZ in
combination with the vector plasmid or recombinant
plasmids encoding various myc-His-tagged CARP-1
mutants that have been described before [4]. Cell lysates
were utilized to immunoprecipitate CARP-1 proteins
using anti-myc-tag antibodies followed by western blotting in conjunction with anti-flag tag antibody. The data
revealed that TAZ-interacting epitope is present within
CARP-1 amino acids 651-759 (Additional file 1A). Similar experimental strategy was utilized to map CARP-1interacting epitope of TAZ by expressing myc-His-tagged
CARP-1 (651-759) mutant in combination with various
plasmids encoding gst-tagged TAZ proteins. We found
that CARP-1 interacted with a novel epitope within the
N-terminal of TAZ, and that TAZ serine 89, WW, PDZ or
coiled-coil motifs were not involved in its binding with
CARP-1 (Additional file 1B). Our mapping studies are
summarized in figure 4, and together with the data in figures 2 and 3 demonstrate that novel motifs of CARP-1
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Figure 2 H89 induces CARP-1 expression (A) and threonine phosphorylation (B), and depletion of CARP-1 abrogates apoptosis by H89 (C).
In panel A, the cells were treated with noted dose of H89 or piceatannol for indicated time periods. Approximately 100 μg of respective protein lysates
were electrophoresed on 10% SDS-PAGE, followed by western immunoblotting. The membranes were first probed with anti-CARP-1 (α2) antibody
[3], followed by probing with anti-actin antibody to assess loading. In panel B, cells were either untreated (Control) or treated with H89 for indicated
dose and time, and cell lysates were prepared. In lanes 2 and 3, co-immunoprecipitation using noted antibodies and 1000 μg protein lysate was carried
out prior to western blotting. In lane 1, 100 μg protein lysate was analyzed along with immunoprecipitates on 10% SDS-PAGE followed by immunoblotting with anti-phospho-tyrosine or anti-phospho-threonine antibodies. In panel C, HBC cells expressing normal (indicated as CARP-1 antisense
sublines 1, 4) or 50% reduced CARP-1 (indicated as sublines 9, 10) were either untreated or treated with noted time and dose of H89, and apoptosis
determined as in figure 1D. Columns in histogram represent data from 3 independent experiments; bars, SE.

and TAZ are involved in their binding, and that TAZ
expression interefers with apoptosis signaling by CARP1.
CARP-1 threonine at position 667 is a target of H89dependent apoptosis signaling

To define mechanisms of H89-dependent apoptosis, we
first determined whether TAZ-interacting CARP-1 (651759) mutant is a target of H89 signaling. To address this
issue, cells expressing myc-His-tagged CARP-1 (651-759)
protein were either untreated or treated with H89. The
protein complex was immunoprecipitated with antiphospho-threonine antibodies, followed by western blotting with anti-myc-tag antibodies. H89 induced threonine phosphorylation of CARP-1 (651-759) protein when
compared with the untreated control (Figure 5A) indicat-

ing that H89 signaling targets threonine residue(s) within
CARP-1 (651-759) protein. Since CARP-1 (651-759)
mutant also harbors TAZ-binding epitope (figure 4), we
next determined whether threonine phosphorylation of
CARP-1 (651-759) regulates CARP-1 binding with TAZ.
On the basis of Prosite database analysis [17] that predicted CARP-1 threonine667 as a high probability phosphorylation site, we generated additional constructs for
expression of CARP-1 (651-759) protein with
threonine667 substituted to either alanine (T667A) or
aspartate (T667D) as detailed in methods. Cells expressing Gst-TAZ (1-120) in combination with myc-Histagged CARP-1 (651-759), CARP-1 (651-759T667A), or
CARP-1 (651-759T667D) proteins were utilized to analyze
protein complexes that were immunoprecipitated with
anti-Gst-tag antibodies followed by western blotting with
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Figure 3 CARP-1 interacts with TAZ (A, B), TAZ expression interferes with CARP-1-dependent apoptosis (C), and CARP-1 and TAZ co-localize
in cytoplasmic/perinuclear region (D). For CARP-1 binding with TAZ, Breast cancer cells (panel A) or HCT-116 colon cancer cells expressing mycHis-tagged wild-type CARP-1 (panel B) were utilized. In panel B, the cells were transfected with plasmids encoding wild-type or mutant TAZ proteins
as indicated, prior to generating cell lysates. The cell lysates were then utilized for immunoprecipitation and western blotting using noted antibodies
essentially as in figure 2C. In panel C, cells were transfected with plasmids encoding vector or wild-type TAZ followed by their transduction with indicated retroviruses expressing vector or wild-type CARP-1 as detailed in methods. The apoptosis levels were assessed by determining the acridine orange-positive cells as described before [4]. Columns in histogram represent data from 3 independent experiments; bars, SE. In panel D, the cells were
transfected with a combination of plasmids encoding myc-His-tagged wild-type CARP-1 and flag-tagged wild-type TAZ proteins, followed by their
fluorescent labeling and photography as described in methods.

anti-myc-tag antibodies. The data revealed that TAZ
binding with CARP-1 (651-759T667A) protein was attenuated (Figure 5B, lane 3). T667D substitution in CARP-1
(651-759) protein, on the other hand, enhanced its binding with TAZ (Figure 5B, lane 4) when compared with
binding of CARP-1 (651-759) with TAZ. Since substitution of phospho-threonine or phospho-serine residue(s)
to aspartate often mimics phosphorylated state of a protein, it is likely that threonine667 to aspartate change
allows a threonine phosphorylated conformation of
CARP-1 (651-759), and favors its binding with TAZ.
Whether CARP-1 threonine667 regulates apoptosis signaling was investigated next. Cells were either untransduced or transduced with viruses encoding vector, mycHis-CARP-1 (651-759), or myc-His-CARP-1 (651759T667A) proteins for 48 h followed by apoptosis determination as in methods. The cells transduced with mycHis-CARP-1 (651-759) displayed significantly enhanced
apoptosis when compared to the apoptosis noted for their
vector-transduced or untransduced counterparts (Figure
5C). Expression of myc-His-CARP-1 (651-759T667A) protein, on the other hand, resulted in lower levels of apopto-

sis when compared to apoptosis noted in myc-HisCARP-1 (651-759) transduced cells (Figure 5C). These
findings suggest that expression of myc-His-CARP-1
(651-759) protein, like wild-type or CARP-1 (603-898)
mutant [4] promotes apoptosis while T667A substitution
interferes with this function.
Since H89 treatments caused elevated CARP-1 expression and apoptosis, while CARP-1 interacts with TAZ,
and TAZ regulates CARP-1-dependent apoptosis (figures
2, 3), we wished to determine whether and to what extent
TAZ regulates H89-dependent apoptosis. For this experiment, we first transduced the HBC cells with viruses
encoding vector or mouse TAZ (wt) protein for a period
of 12 h. The cells were then either untreated or treated
with H89 for additional 48 h, followed by determination
of apoptosis. Although, exposure to H89 caused statistically significant increase in apoptosis of vector transduced cells, it failed to promote apoptosis in TAZtransduced cells (Figure 5D). These findings suggest that
TAZ interferes with apoptosis signaling by H89, and
together with the data in figures 2, 3 and 4 indicate that
CARP-1 threonine phosphorylation following H89 treat-

Jiang et al. Journal of Molecular Signaling 2010, 5:7
http://www.jmolecularsignaling.com/content/5/1/7

Page 6 of 12

TAZ
Interaction

CARP-1 and its Mutants

1

NA
ck R
-sho omain
d
l
o
d
C
ing
bind

A
l DN ain
m
elica
Bih ing do
d
bin

603

1150

898

TAZ and its
Mutants



1



1

oil
in
d-c
ma oile ain
o
d
C om
W
d
395
W

S89A

395

1
759

651
760

898

T667A
759

651
T667D
651

759






1

391
391

S89A

1

1

CARP-1
Interaction

164







120


165

395



Figure 4 CARP-1 (651-759) binds with TAZ (1-120). Schematic diagram of CARP-1 (WT and its various mutants; Left Box) and TAZ (WT and its mutants; Right Box) constructs that were utilized to map minimal epitopes for their interaction. All CARP-1 proteins have myc and 6 × His epitopes at their
carboxyl termini. All the TAZ proteins, with the exception of 1-120, 1-164, and 165-395, harbored flag epitope at their amino termini, while TAZ 1-120
and its 1-164 and 165-395 mutants had Gst epitope at their amino termini. Positive interactions are indicated by + and loss/absence of interaction is
denoted by -.

ment promotes TAZ sequestration by CARP-1 that, in
part, contributes to CARP-1-dependent growth suppression by H89.
Apoptosis signaling by H89 or CARP-1 target c-myc
expression

Since we previously found that CARP-1 negatively regulates c-myc expression [3], we wished to determine
whether and to what extent expression of cell proliferation regulatory genes such as c-myc and topoisomerase
IIα are a target of CARP-1-mediated H89 signaling and
the mechanisms involved therein. To test this possibility,
we first determined whether expression of c-myc and
topoisomerase IIα is inhibited by CARP-1 and its TAZinteracting mutants. Expression of wild-type CARP-1 or
its TAZ-interacting mutants {CARP-1 (603-898) or
CARP-1 (651-759) proteins} resulted in reduced levels of
c-myc as well as topoisomerase IIα when compared with
their vector-transduced counterparts (Figure 6A). Furthermore, treatments with H89 or piceatannol also
resulted in diminished c-myc expression in HBC cells
when compared with their untreated counterparts (Figure 6B). Since, H89 causes elevated expression of CARP-1
and apoptosis, the findings in figure 6A and 6B suggest
that cell growth inhibition following H89 treatments are
due, in part, to CARP-1-dependent loss of cell growth
promoting factors such as c-myc.
In the next set of experiments, we investigated the
mechanism(s) of H89-dependent loss of c-myc expression. Since TAZ is a transcriptional co-activator and

CARP-1 is also a regulator of nuclear receptor complex
[6,8], we first examined whether CARP-1 induction following H89 treatment attenuates c-myc transcription. To
this end, we utilized a plasmid where luciferase reporter
is driven by a mouse c-myc promoter from positions 1138 to +580 relative to the P1 transcription start site
[18,19]. As expected, significant loss of c-myc promoter
activity was noted in H89-treated HBC cells (Figure 6C,
top left). The extent of CARP-1 attenuated c-myc transcription was further investigated by transducing c-myc
promoter-luciferase reporter-transfected HBC cells with
retroviruses encoding vector, wild-type CARP-1, or
CARP-1 (651-759) proteins. Expression of wild-type
CARP-1 or its TAZ-interacting 651-759 mutant caused
significant loss of c-myc promoter activity when compared with their vector-transduced counterparts (Figure
6C, top right). Additional transfection studies revealed
that CARP-1/TAZ-responsive element(s) is located
within -140 to +310 region of the mouse c-myc promoter
(Figure 6C, lower). Taken together, data in figure 6 demonstrate that attenuation of c-myc expression by H89 or
CARP-1 is accomplished, in part, by transcriptional
down-regulation of c-myc, and contributes to the growth
suppressing effects of CARP-1 and H89.

Discussion
We previously reported identification and characterization of CARP-1/CCAR1, a peri-nuclear phospho-protein
that mediates apoptosis signaling by diverse agents
including adriamycin and inhibitors of EGFRs [3,4]. The
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Figure 5 CARP-1 threonine667 is a target of H89 signaling, regulates CARP-1-TAZ binding, and CARP-1-dependent apoptosis. (A) Cells transfected with plasmid encoding myc-His-tagged CARP-1 (651-759) mutant were either untreated (Control) or treated with H89 for indicated dose and
time, and cell lysates were prepared, and protein lysate subjected to immunoprecipitation using phospho-theronine antibodies (noted as P-Thr Ab),
and protein lysate (100 μg, lane indicated with -) along with immunoprecipitates (lanes indicated with +) analyzed by western blotting with anti-myctag antibody. (B) Cells were transfected with plasmid encoding flag-tagged TAZ (1-120) mutant [indicated as pEBG-TAZ (1-120)] in combination with
plasmids expressing noted myc-His-tagged CARP-1 mutant proteins. The cell lysates in lanes 2, 3, and 4 were subjected to immunoprecipitation using
anti-Gst tag antibodies essentially as in figure 4B. Protein lysate and immunoprecipitates analyzed by western blotting as in panel A. Presence of CARP1 (651-759) proteins is indicated on the left side of each panel. (C) Cells were either untransduced (Control), or transduced with retroviruses expressing
vector or myc-His-tagged CARP-1 mutants. (D) Cells were transduced with retroviruses encoding vector plasmid or wild-type TAZ followed by treatments with H89 for noted dose and time. Protein lysates in both panels C and D were assayed for apoptosis essentially as in figure 1D. Columns in
histograms represent data from 2 independent experiments; bars, SE. Data in panels C and D were analyzed using a two-tailed Student t test. For panel
C, *P < 0.005, while for panel D, *P < 0.0087, compared to the corresponding vector controls.

micro-array-based approach revealed that CARP-1dependent cell growth inhibition involves cell cycle regulatory proteins such as c-Myc and cyclin B1 [3]. Since
attenuation of PKA often inhibits cell growth we wished
to investigate whether CARP-1 was involved in this signaling. Our studies revealed that H89, a commonly utilized pharmacologic inhibitor of PKA-Cα, inhibited cell
growth in part by inducing apoptosis. The fact that a
number of recent studies have implicated H89 as an
inhibitor of other kinases such as the MSK1 and the ribosomal S6Kinase [reviewed in ref [14]], we first clarified
whether apoptosis induction by H89 involved its targeting of PKA-Cα, MSK1, or S6Kinases. Surprisingly, SiRNA-dependent knock-down of either of these kinases

failed to induce apoptosis in HBC cells. Furthermore,
HBC cells that were treated with various doses of RpcAMPS, a competitive antagonist of the cyclic nucleotide-binding domain on PKA, over a range of time periods also failed to stimulate apoptosis (not shown). Our
Si-RNA-based experiments therefore suggest that H89
likely inhibits cell growth independent of its targeting of
the PKA-Cα, MSK1, or S6Kinases and may point to additional cell growth inhibitory mechanisms utilized by this
agent. The fact that CARP-1 was involved in transducing
H89 signaling as noted in our current studies, we propose
that CARP-1-dependent H89 inhibition of HBC cell
growth is a novel pathway (Figure 6D).
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Figure 6 Expression of CARP-1 (A) or H89 treatment (B) causes reduced c-myc levels, in part by suppressing c-myc transcription (C). Cells
were transduced with retroviruses encoding vector or CARP-1 proteins as indicated in panel A. For panel B, HBC cells were either untreated or treated
with indicated doses of H89 or piceatannol. Approximately 100 μg of respective protein lysate was analyzed by SDS-PAGE, followed by western immunoblotting with either anti c-myc or topoisomerase IIα antibodies essentially as in methods. The membrane was subsequently probed with antiactin antibody to assess loading. Presence of c-myc, topoisomerase IIα and actin proteins is denoted on the left side of each panel. In panel C, HBC
cells were transfected with indicated c-myc promoter-luciferase reporter plasmid. The cells were either untreated (Control) or treated with H89. In
addition, the HBC cells were separately transfected with luciferase reporter plasmids having full length c-myc promoter or its various deletions, followed by their transduction with retroviruses encoding vector or CARP-1 protein. The cell lysates were analyzed for luciferase reporter activities as in
methods. Columns in the histograms represent means of two independent experiments; bars, SE. Data were analyzed using a two-tailed Student t
test. For top left histogram, *P < 0.044, compared to the corresponding control, and for the lower histogram, *P < 0.0055 and **P < 0.006, compared
to the respective vector-transduced controls. Panel D, Schematic of CARP-1-dependent growth suppression signaling in the presence of H89. = , Binding.

CARP-1 and its mutants suppress cell growth in part by
activating intrinsic apoptosis pathway [4]. Moreover,
CARP-1 interacted with cytoplasmic signaling transducer
14-3-3/Stratifin protein, while over-expression of stratifin
interfered with CARP-1-dependent apoptosis [3]. An
array of cell growth regulators such as Raf, PI-3 kinase,
MEKK, BAD, ASK-1, cdc25, CDK25, p53, FKHRL, and
TAZ serve as substrates for binding with 14-3-3 proteins.
TAZ, in particular, interacts with 14-3-3 protein in a
phsophorylation-dependent manner, and in the light of
our data demonstrating CARP-1 binding with TAZ, and
the fact that overexpression of TAZ attenuates CARP-1dependent apoptosis (figures 4 and 5), suggests for exis-

tence of a dynamic multiprotein cytoplasmic complex
that functions to regulate cell growth. This complex is a
target of phosphorylation signaling by H89 is further supported by our data in figure 5 showing TAZ-binding subdomain of CARP-1 (CARP-1 651-759) is a target of threonine phopshorylation by H89, and that the threonine667
regulates CARP-1 binding with TAZ and subsequent
apoptosis.
Since, CARP-1 has a novel serine-phosphorylation
motif [16], and the fact that 14-3-3 proteins often bind to
serine/threonine-phosphorylated residues in their target
proteins [20,21] it is unclear whether CARP-1 interactions with 14-3-3/Stratifin are dependent on prior spe-
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cific serine/threonine phosphorylation of CARP-1.
CARP-1 binding with TAZ, on the other hand, is dependent on phosphorylation of CARP-1 threonine667 without
the involvement of TAZ WW, PDZ domain protein binding, and 14-3-3-interacting motifs as reflected by our data
in figure 4. Since TAZ appears to have a novel motif for
binding with CARP-1, it is likely that TAZ mediates
CARP-1 sequestration by 14-3-3 in a manner dependent
on phosphorylation of both the TAZ and CARP-1 proteins, in turn promoting the formation of a multiprotein
cytoplasmic complex. The enhanced threonine phosphorylation and expression of CARP-1 in the presence of
H89 likely favors cytoplsmic sequestration of TAZ, and
consequently interferes with nuclear translocation and
transcriptional co-activation function of TAZ.
A range of transcription factors target specific cissequences within the c-myc promoter and enhancer
region in a manner that is often dependent on the cell
type as well as context of the signaling pathway [22]. For
example, PDGF-dependent mitogenic signaling regulates
c-Myc expression through multiple pathways that target
c-myc promoter elements [23,24]. The PDGF activates cmyc transcription through a JNK and AP-1/c-fos/c-Jundependent pathway that targets a canonical AP-1 consensus element located ~1.3 kb upstream of the P1 start site
[23], while PDGF-dependent c-myc expression is also
regulated through Rho GTPases involving a region from 157 to +500 relative to P1 transcription start site of c-myc
promoter [24]. In the latter case, however, the precise
nature of the cis-trans elements remains to be elucidated.
Although, TAZ is a transcriptional co-activator of proteins with PPXY motifs, that include a growing list of
transcription factors such as c-Jun [8], and the fact that
CARP-1-TAZ interactions following H89 treatments
interfere with c-myc transcription (figure 6) while the
AP-1 consensus sequences are located outside of the
region targeted by H89 or CARP-1 (see figure 6) suggest
that H89-dependent TAZ-CARP-1 signaling is unlikely to
interfere with AP-1 function. However, of note is the fact
that the H89-responsive mouse c-myc promoter region (140 to +310 relative to P1 start site, figure 6) overlaps
with -157 to +500 region of human c-myc promoter
sequences that are targeted by PDGF through the Rho
GTPases. Whether the two signaling pathways indeed
share a common transcription factor(s) that target known
and/or novel cis sequences remains to be clarified.

Conclusion
H89 utilizes a novel pathway to regulate HBC cell growth
in a manner involving elevated threonine phosphorylation of CARP-1, its binding with a transcriptional co-activator TAZ, and repression of c-myc.
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Methods
Materials

DMEM, Ham's F-12 medium, fetal bovine serum (FBS),
and lipofectamine-based transfection kit were purchased
from Life Technologies, Inc., Grand Island, NY. Piceatannol, H89, Rp-cAMPS (a competitive antagonist of the
cyclic nucleotide-binding domain on PKA), and SpcAMPS (a competitive agonist of the cyclic nucleotidebinding domain on PKA) were obtained from Calbiochem/EMD Biosciences (San Diego, CA). The anti-PKA
Cα, anti-phospho-PKA C (Thr197) polyclonal antibodies,
anti-MSK1, anti-ribosomal S-6-kinase, as well as antimyc-tag mouse monoclonal (9B11) antibodies were purchased from Cell Signaling (Beverley, MA). Anti-flag M2
and anti-c-myc (clone 67P05) monoclonal antibodies
were obtained from Sigma-Aldrich, (St. Louis, MO) and
Lab Vision (Fremont, CA), respectively. Anti-phosphotyrosine and anti-phospho-serine antibodies were purchased from Zymed labs (San Francisco, CA), while Antiphospho-threonine (H-2) HRP conjugate were from
Santa Cruz Biotech (Santa Cruz, CA). Anti-topoisomerase IIα mouse monoclonal (3F6) antibody was from
Novacastra/Vector laboratories, Burlingame, CA, and
anti-Gst rabbit polyclonal antibody was purchased from
Upstate Biotech, Lake placid, NY. Phospho-enrichment
beads were purchased from BD Biosciences (Palo Alto,
CA).
Recombinant plasmid constructs

The construction of plasmid clone 6.1 expressing mycHis-tagged wild-type CARP-1 as well as clone 1.6
expressing CARP-1 antisense has been described before
[3]. The plasmids pEF-TAZ-N-Flag, pEF-TAZ(-4)-NFlag, and pEF-TAZ(S89A)-N-Flag that encode wild type
or mutant TAZ proteins were as detailed before [8]. The
plasmids encoding N-terminal gst epitope tagged wild
type or mutants TAZ proteins were generated by PCR
amplification using mouse TAZ cDNA as template followed by their cloning into the pEBG vector plasmid. The
plasmid pEBG-TAZ (wt) encodes Gst-tagged wild-type
TAZ, while pEBG-TAZ (1-164), pEBG-TAZ (165-395),
and pEBG-TAZ (1-120) encode Gst-tagged truncated
mouse TAZ proteins. Of note is that fact that the mutant
TAZ (1-120) lacks the WW domain that has been implicated in TAZ interactions with PPXY motif of nuclear
transcription factors such as c-Jun [8]. In addition,
recombinant plasmids for expression of mutant CARP-1
proteins were generated by a combination of standard
PCR amplification and cloning methodologies to generate constructs that encode CARP-1 proteins having myc
and His tags positioned at the carboxyl termini. Constructs encoding CARP-1 (651-759) protein having threonine at position 667 substituted with alanine or
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aspartate were similarly generated using a combination of
PCR amplification and cloning methods. All the recombinant plasmids were sequenced to ascertain validity of the
cDNA inserts. The plasmids having mouse c-myc promoter (-1138 to +580, -426 to +580, -140 to +310, and 140 to +175 relative to the P1 transcription site) driving
luciferase reporter gene have been described before
[18,19].
Cell Lines and Cell Culture

ER-negative, p53-negative SKBR-3, MDA-MB-468 HBC
cells, and their sublines expressing CARP-1 antisense
(Clone 1.6 sublines 1, 4, 9, and 10), as well as human
colon cancer HCT-116 cells were cultured and maintained as detailed before [3,19]. HCT-116 sublines stably
expressing vector plasmid or myc-His-tagged wild type
CARP-1 were isolated and characterized as described
before [4]. Monkey kidney COS-7 and NIH3T3 mouse
fibroblast cells were obtained from ATCC (Manassas,
VA) and propagated per vendor's suggestions. NIH3T3
derivative PT-67 mouse fibroblasts were purchased from
BD-Clontech (Palo Alto, CA), and generation and characterization of their stable isolates expressing vector
pLNCX2, myc-His-tagged wild-type or mutant CARP-1
proteins was carried out as previously described [3,4].
Luciferase assays

Cells were plated either in a 60-mm dish or in a 6-well
plate at a density of 3 × 105 cells/ml and then co-transfected with pTK/Renilla Luc in combination with various
c-myc-Promoter-luc constructs essentially following previously detailed methods [3,4,25]. After 6-h incubation
with plasmid DNAs, cells were washed three times with 1
× PBS, co-incubated with retroviruses encoding vector,
wild-type or mutant CARP-1 proteins, and allowed to
grow in the appropriate culture media for additional 48 h.
The cells were then harvested, lysed, and Renilla and firefly luciferase activities were measured using dual
luciferase assay kit (Clontech) essentially following vendors guidelines.
Gene Knock-down experiments

CARP-1 expression was down-regulated in HBC cells by
stably expressing a plasmid expressing CARP-1 antisense
cDNA. Antisense transfected sublines 1, 4 express normal levels, while sublines 9 and 10 express 50% reduced
levels of CARP-1 and their characterization has been
detailed before [3]. Depletion of PKA-Cα, CARP-1, S6K,
or MSK1 was carried out by transfecting MDA-MB-468
HBC cells with scrambled (non-target) or respective specific on-target Si-RNAs (Dharmacon) following manufacturer suggested guidelines. Seventy-two hours posttransfections, the cell lysates were analyzed by western
immunoblotting in conjunction with respective antibod-
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ies essentially following the methodologies detailed
below.
Immunoprecipitation, Western Blot, Apoptosis, and Colocalization Assays

Logarithmically growing cells were either untransfected
or transfected with various plasmids for 24 or 48 hours
followed by their lysis to prepare protein extracts. In certain instances cells were treated with H89. For immunoprecipitation aliquots of cell lysates containing 1.0 mg
proteins were incubated with indicated antibodies and
Sepharose G at 4°C for 3 hours. Immunoprecipitates or
the protein extracts were then analyzed by western blotting using indicated antibodies per the manufacturer's
guidelines and previously published protocols [3,4,19].
For enrichment of phosphorylated proteins, the cells
were first transfected with plasmids encoding wild-type
or mutant CARP-1 proteins, followed by treatments of
cells with H89. Equal amounts (1 mg) of cell lysates were
then applied to phospho-protein enrichment columns;
the complexes were washed and eluted following manufacturer suggested methodology. The enriched phosphoproteins alongwith the protein lysate from transfected
cells were analyzed by western blotting first with antimyc tag antibodies followed by reprobing with anti-phospho-tyrosine antibodies. In addition, cell lysates were
prepared from untreated as well as treated cells to determine apoptosis by utilizing cell death detection ELISA kit
(Roche Diagnostics). The net absorbances at the suggested wavelengths (A405nm minus A495nm) were
obtained for the lysates derived from treated as well as
untreated cells. The histograms indicating levels of apoptosis were generated either by plotting net absorbances or
by calculating the "enrichment factor" as described [3,4].
In certain instances, cell death was measured by counting
acridine orange-ethidium bromide stained cells [25],
while viabilities of untreated and treated cells were also
measured by utilizing LIVE/DEAD viability/cytotoxicity
assay (Molecular Probes, Eugene, OR).
COS-7 cells were transfected with plasmid expressing
myc-His-tagged wild-type CARP-1 (CARP-1 clone 6.1;
ref. [3]) in combination with plasmid expressing wildtype TAZ (pEF/mTAZ-N-Flag, ref. [8]). The cells were
trypsinized, fixed, and permeablizied followed by incubation with a combination of anti-Flag tag mouse monoclonal and anti-myc tag rabbit polyclonal antibodies at 4°C
for overnight. The cells were washed again in 1 × PBS for
three times, and incubated with a combination of rhodamine conjugated goat-anti-rabbit and Alexa 488 conjugated goat-anti-mouse IGg for a period of 30 min at 37°C.
The cells were washed twice with pre-warmed 1 × PBS,
and coverslips were mounted with an aqueous-based
anti-fade medium. The cell fluorescence was detected by
an Olympus BX51 fluorescent microscope fitted with a
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triple DAPI/FITC/TRITC cube, and the images were captured by a DP70 digital camera and image acquisition
software. The exposure time and magnification (400×)
were maintained throughout the capture of images. The
images were subsequently analyzed by Image analysis and
Adobe Photoshop software.

Additional material
Additional file 1 Supplemental Figure. CARP-1 (651-759) binds with TAZ
(1-120). Cells were transfected with plasmid encoding flag-tagged wildtype TAZ in combination vector or plasmids expressing noted myc-Histagged CARP-1 mutant proteins (panel A), or the indicated combinations of
myc-His-tagged CARP-1 (651-759) and gst-tagged TAZ mutants (panel B).
The immunoprecipitation and western blotting were carried out using
noted antibodies essentially as in figure 3. In panel A, the membranes were
subsequently probed with anti-myc-tag antibodies to assess expression of
respective CARP-1 mutant protein.
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